ISSN 2398-2969      

Hyperadrenocorticism

icanis

Synonym(s): Cushing's syndrome, HAC


Introduction

  • Relatively common endocrine disease.
  • Cause: syndrome resulting from excessive production or administration of glucocorticoids.
  • Signs: polydipsia, polyuria, polyphagia, alopecia, lethargy.
  • Diagnosis: screening lab tests and dynamic tests of adrenal function.
  • Treatment: trilostane, mitotane.
  • Prognosis: good with adequate monitoring.

    Print out owner factsheet on Cushing's disease (hyperadrenocorticism) Cushing's disease (hyperadrenocorticism) to give to your client.Follow the diagnostic tree for Trilostane Treatment for Canine Pituitary-Dependent Hyperadrenocorticism Diagnostic tree: Trilostane Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.

Pathogenesis

Etiology

  • Iatrogenic associated with prolonged corticosteroid therapy.
  • For pathophysiology see adrenal pathophysiology Adrenal: anatomy and physiology.
  • Failure of negative feedback on ACTH release.
  • Functional pituitary tumor (corticotrophic adenoma).
  • Functional adrenal tumor - usually unilateral with 50% benign, 50% malignant.

Pathophysiology

  • Glucocorticoids profoundly affect carbohydrate, protein and fat metabolism.
  • Glucocorticoids also modify inflammatory and immune responses.
  • Excessive glucocorticoids cause:

Liver

  • Increased gluconeogenesis.
  • Increased glycogen stores.
  • Induce certain enzymes.

Muscle

  • Increased protein catabolism → muscle wasting and weakness.

Bone

  • Microscopic osteopenia associated with increased PTH, increased protein catabolism and negative calcium balance. Dogs with hyperadrenocorticism do not get clinically detectable osteoporosis (cf humans).

Skin

  • Increased protein catabolism → thin skin, poor wound healing, poor scar formation, cessation of hair growth.

Blood

  • Erythrocytosis.
  • Decrease in circulating lymphocytes and eosinophils.
  • Increase in circulating neutrophils.

Kidney

  • Increased glomerular filtration rate or interference with ADH release or action → polyuria → polydipsia.
  • Increased calcium excretion.

Immune system

  • Reduced inflammatory response.
  • Reduced immune response.

Fat

  • Increased lipolysis.
  • Redistributed fat deposits.

Genital system

  • Reduced gonadotrophins → anestrus in bitch/testicular atrophy in dog.

Timecourse

  • Months → years.

Diagnosis

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Treatment

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Outcomes

This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Ramsey I & Ristic J (2007) Diagnosis of canine hyperadrenocorticism. In Practice 29 (8), 446-454 VetMedResource.
  • Ramsey I & Neiger R (2007) Treatment of canine hyperadrenocorticism. In Practice 29 (9), 512-519 VetMedResource.
  • Bell R, Neiger R, McGrotty Y & Ramsey I K (2006) Study of the effects of once daily trilostane administration on cortisol concentrations and ACTH responsiveness in hyperadrenocorticoid dogs. Vet Rec 159 (9), 277-281 PubMed.
  • Ramsey I (2006) Treatment of canine hyperadrenocorticism. UK Vet 11 (2), 27-32 VetMedResource.
  • Ramsey I (2006) Diagnosis of canine hyperadrenocorticism. UK Vet 11 (1), 21-28 MAGOnlineLibrary.
  • Ramsey I (2006) Pathophysiology of hyperadrenocorticism. UK Vet 10 (8), 31-37.
  • Barker E, Campbell S, Tebb A, Neiger R, Herrtage M E & Ramsey I K (2005) A comparison of the survival times of dogs treated for hyperadrenocorticism with trilostane or mitotane. J Vet Intern Med 19 (6), 810-815 PubMed.
  • Ramsey I K, Tebb A, Harris E, Evans H & Herrtage M E (2005) Hyperparathyroidism in dogs with hyperadrenocorticism. JSAP 46 (11), 531-536 PubMed.
  • Tebb A J, Arteaga A, Evans H & Ramsey I K (2005) Canine hyperadrenocorticism: effects of trilostane on parathyroid hormone, calcium and phosphate concentrations. JSAP 46 (11), 537-542 PubMed.
  • Wenger M, Sieber-Ruckstuhl N S, Muller C & Reusch C E (2004) Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocorticism. Am J Vet Res 65 (9), 1245-1250 PubMed.
  • Neiger R (2003) Treatment of canine hyperadrenocorticism (Cushing's Disease) with trilostane. UK Vet (2) 19-22.
  • Neiger R, Ramsey I K, O'Connor J, Hurley K & Mooney C T (2002) Trilostane treatment of 78 dogs with pituitary dependent hyperadrenocorticism. Vet Rec 150 (26), 799-804 PubMed.
  • Ruckstuhl N S, Nett C S & Reusch C E (2002) Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 63 (4), 506-512 PubMed.
  • Gould S M, Baines E A, Mannion P A, Evans H & Herrtage M E (2001) Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism. JSAP 42 (3), 113-121 PubMed.
  • Frank L A, DeNovo R C, Kraje A C et al (2000) Cortisol concentrations following stimulation of healthy and adrenopathic dogs with two doses of tetracosactrin. JSAP 41 (7), 308-311 PubMed.
  • Reusch C E, Steffen T & Hoerauf A (1999) The efficacy of L-Deprenyl in dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 13 (4), 291-301 PubMed.
  • Zerbe C A et al (1999) The Hypothalamic-Pituitary-Adrenal Axis and Pathophysiology of Hyperadrenocorticism. Comp Contin Educ Pract Vet 21 (12), 1134-1137 VetMedResource.
  • Hess R S, Kass P H & Ward C R (1998) Association between hyperadrenocorticism and development of calcium-containing uroliths in dogs with urolithiasis. JAVMA 212 (12), 1889-1891 PubMed.
  • Théon A P & Feldman E C (1998) Megavoltage irradiation of pituitary macrotumors in dogs with neurologic signs. JAVMA 213 (2), 225-231 PubMed.
  • Thuróczy J, van Sluijs F J, Kooistra H S et al (1998) Multiple endocrine neoplasms in a dog - corticotrophic tumor, bilateral adrenocortical tumors, and pheochromocytoma. Vet Q 20 (2), 56-61 VetMedResource.
  • Angles J M, Feldman E C, Nelson R W et al (1997) Use of urine cortisol-creatinine ratio versus adrenocorticotropic hormone stimulation testing for monitoring mitotane treatment of pituitary-dependent hyperadrenocorticism in dogs. JAVMA 211 (8), 1002-1004 PubMed.
  • Dunn K J (1996) Complications associated with the diagnosis and management of canine hyperadrenocorticism. In Practice 19 (5), 246-52 VetMedResource.
  • Grooters A M, Theisen S K et al (1996) Ultrasonographic characteristics of the adrenal glands in dogs with PDH - comparison with normal dogs. JVIM 10 (3), 110-115 PubMed.
  • Bertoy E H, Feldman E C, Nelson R Wet al (1995) MRI of the brain of dogs with recently diagnosed but untreated pituitary dependent hyperadrenocorticism. JAVMA 206 (5), 651-656 PubMed.
  • van Sluijs F J, Sjollema B E, Voorhout G, van der Ingh T S G A M & Rijnberk A (1995) Results of adrenalectomy in 36 dogs with hyperadrenocorticism​ caused by adrenocortical tumor. Vet Q 17 (3), 113-116 PubMed.
  • Kintzer P P & Peterson M E (1994) Mitotane treatment of 32 dogs with cortisol-secreting adrenocortical neoplasms. JAVMA 205 (1), 54-61 PubMed.
  • Kintzer P P & Peterson M E (1991) Mitotane (o,p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 5 (3), 182-190 PubMed.

Related Images

RELATED ARTICLES

Abdominal organomegaly

Acanthosis nigricans

ACTH

ACTH Assay

ACTH stimulation test

Adrenal: anatomy and physiology

Blepharitis

Blood biochemistry: alkaline phosphatase (ALP)

Blood biochemistry: bile acids

Blood biochemistry: cholesterol

Blood biochemistry: glucose

Blood biochemistry: urea

Bromocriptine

Collapse

Computed tomography

Congenital panhypopituitarism

Cyproheptadine

Cystitis

Dachshund

Dexamethasone

Diabetes insipidus: nephrogenic

Diabetes mellitus

Diabetes mellitus: complications of treatment

Diabetes mellitus: pathophysiology

Ear: aural hematoma

Glomerulonephritis

Hematology: eosinophil

Hematology: lymphocyte

Hemostatic disorder: acquired

High-dose dexamethasone suppression test

Hypercalcemia: overview

Hyperlipidemia

Hyperosmolar hyperglycemic state

Hypertension

Hypoadrenocorticism

Hypothyroidism

Intracranial hemorrhage

Ketoconazole

Kidney: pyelonephritis

Kidney: thromboembolism

Liver function assessment

Liver: steroid hepatopathy

Low-dose dexamethasone suppression test

Lung: pulmonary thromboembolism

Magnetic resonance imaging: brain

Methylprednisolone

Mitotane

Myotonic myopathy (myotonia)

Nephrotoxicosis

Nutritional secondary hyperparathyroidism

Obesity

Pancreatitis: acute

Perianal neoplasia

Pituitary adenoma

Pituitary gland: neoplasia

Polyuria/polydispia (PU/PD)

Poodle: Miniature

Poodle: Toy

Prednisolone

Pre-trilostane cortisol monitoring

Pyometra

Radiography: abdomen

Radiography: thorax

Radiology: liver

Radiology: lungs

Radiotherapy

Retina: sudden acquired retinal degeneration syndrome

Selegiline hydrochloride

Skin: acral lick granuloma

Skin: alopecia - overview

Skin: alopecia X

Skin: candidiasis

Skin: color dilution alopecia

Skin: comedo syndrome (Schnauzer)

Skin: deep folliculitis and furunculosis

Skin: deep pyoderma

Skin: demodectic mange

Skin: hyperandrogenism

Skin: hyperestrogenism

Skin: hypoandrogenism

Skin: hypo-estrogenism

Skin: hyposomatotropism

Skin: idiopathic cyclic flank alopecia

Skin: pattern baldness

Skin: pigmentary disorders

Skin: pododermatitis and furunculosis

Skin: primary seborrhea

Skin: thyroid-responsive alopecia

Therapeutics: antimicrobial drug

Trilostane

Ultrasonography: adrenal gland

Ultrasonography: liver

Urinalysis: glucose

Urinalysis: protein

Urinalysis: specific gravity

Urinalysis: white blood cell

Urine cortisol:creatinine ratio

Yorkshire Terrier

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!

 
 
 
 

To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code